(ALC) Alcon - Ratings and Ratios

Alcon AG (SW:ALC) is a global leader in eye care, specializing in the research, development, manufacturing, and distribution of a wide range of ophthalmic products and technologies. The company operates through two primary segments: Surgical and Vision Care. The Surgical segment focuses on equipment, instrumentation, and diagnostics for cataract and refractive surgery, including intraocular lenses (IOLs), implantables, and advanced surgical systems. The Vision Care segment offers consumables such as contact lenses, ocular health products, and solutions for dry eye, allergies, and glaucoma.

Alcons Surgical portfolio includes cutting-edge technologies like the Centurion Vision System, LenSx Laser System, and the NGENUITY 3D Visualization System, which enhance precision and outcomes in cataract and refractive surgeries. Its IOL offerings include monofocal, Toric, and Presbyopia-Correcting lenses, designed to address various vision correction needs. The company also provides vitreoretinal products, including constellation vision systems and medical-grade vitreous tamponades, as well as refractive surgery solutions like WaveLight and Contoura Vision for LASIK procedures.

In the Vision Care segment, Alcon markets a diverse range of contact lenses, including daily disposables, reusable lenses, and color-enhancing options. Its ocular health portfolio spans dry eye treatments, glaucoma medications, and contact lens care products. The company also offers ocular vitamins and redness relievers, addressing a broad spectrum of eye care needs. Alcons commitment to innovation has established it as a trusted partner for eye care professionals and patients worldwide.

Founded in 1945 and headquartered in Geneva, Switzerland, Alcon Inc. was formerly known as Alcon Universal S.A. and adopted its current name in December 2001. The company has a strong global presence, with a focus on advancing eye care through continuous innovation and strategic investments in research and development.

Web URL: https://www.alcon.com

3-Month Forecast:

Based on and , Alcon AG (SW:ALC) is expected to face near-term headwinds due to its current price trading below key moving averages (SMA 20: 77.50, SMA 50: 79.63). The stocks ATR of 2.51 suggests moderate volatility, with potential downside risks if the broader market weakens. However, the forward P/E of 25.64 indicates investor expectations for improved earnings growth, supported by the companys strong portfolio of eye care products and ongoing innovation efforts. The P/S ratio of 3.63 reflects a premium valuation, which may be challenged if revenue growth slows. Overall, the stock is likely to remain range-bound in the near term, with upside limited by technical resistance levels and downside cushioned by its robust market position.